Toxicology Drug Screening Market
Toxicology Drug Screening Market Forecasts to 2030 - Global Analysis By Type (Cardiovascular Disease Drug Screening, Obesity Drug Screening, Diabetes Drug Screening and Other Types), Test Type (Acute Systemic Toxicity, Dermal Toxicity, Carcinogenicity, Ocular Toxicity, Genotoxicity, Neurotoxicity, Organ-Specific Toxicity and Other Test Types), Technology, End User and by Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $13.34 BN |
|
Projected Year Value (2030) |
US $27.30 BN |
|
CAGR (2023 - 2030) |
10.77% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Toxicology Drug Screening Market is accounted for $13.34 billion in 2023 and is expected to reach $27.30 billion by 2030 growing at a CAGR of 10.77% during the forecast period. One essential part of medical diagnostics is toxicology drug screening, which looks for drugs or their metabolites in biological samples like blood, urine, or hair. In a number of contexts, such as workplace testing, forensic investigations, and clinical evaluations, this procedure is essential. Moreover, toxicology drug screening can detect a variety of substances, including toxins, illicit drugs, and prescription medications, by using advanced analytical techniques like chromatography-mass spectrometry and immunoassays.
According to the IFPMA's 2021 report, the annual R&D spending by the biopharmaceutical industry is 7.3 times higher than that of the aerospace and defense industries, 6.5 times more than the chemicals industry, and 1.5 times more than the software and computer services industry.
Market Dynamics:
Driver:
Growing number of cases of substance abuse
One of the main factors propelling the toxicology drug screening market is the rising incidence of substance abuse, which includes both conventional drugs and newly developed synthetic substances. Additionally, particularly in light of the opioid crisis, there is a greater need than ever for efficient screening methods that identifies and treats drug abuse. In response to this driver, the market has developed novel testing methodologies that can detect a wide range of substances, including new designer drugs that present challenges to established screening techniques.
Restraint:
Difficulties in identifying novel substances
The quick rise of designer drugs and new psychoactive substances (NPS), which continuously complicate conventional toxicology screening techniques, is one major barrier. As the world of substance abuse changes, screening assays find it challenging to keep up with the dynamic nature of illicit drug formulations. Furthermore, enhancing screening capabilities through ongoing research and development is necessary to adjust to the detection of novel compounds.
Opportunity:
Development of cutting-edge screening technologies
The development of more sophisticated and all-encompassing screening technologies has a great deal of potential. Improved sensitivity, specificity, and the capacity to detect a wider variety of substances can result from ongoing research and innovation in analytical techniques like mass spectrometry and chromatography. Moreover, putting money into state-of-the-art technologies puts stakeholders in a position to more accurately and efficiently handle the changing demands of toxicology screening.
Threat:
Designer drugs quick evolution
The development of designer drugs and novel psychoactive substances (NPS) presents a serious threat to established toxicology screening techniques. These substances are evolving quickly, which makes it difficult for screening assays to identify and detect new compounds. Additionally, this could result in false negative results and reduce the effectiveness of drug testing.
Covid-19 Impact:
The COVID-19 pandemic has had a profound effect on the market for toxicology drug screening, changing healthcare priorities and procedures. Drug testing programs and other regular healthcare services have been disrupted as a result of the focus on solving the public health emergency. Although there was still a need for toxicology screening, especially for critical workers and in emergency rooms, the pandemic created difficulties for sample collection, laboratory operations, and general logistics. Furthermore, decisions to invest in cutting-edge toxicology technologies were influenced by budgetary constraints and economic uncertainties during the pandemic.
The Cardiovascular Disease Drug Screening segment is expected to be the largest during the forecast period
The cardiovascular disease drug screening segment is projected to hold the largest share. The world's leading causes of morbidity and mortality are cardiovascular diseases, which include ailments like dyslipidemia and hypertension. Thus, one of the most important aspects of pharmaceutical research and development is drug screening for cardiovascular diseases. Moreover, the identification of drugs and treatments that target heart and vascular health risk factors, such as blood pressure, cholesterol, and clotting factors, is central to the cardiovascular drug screening market.
The Diagnostic Laboratories segment is expected to have the highest CAGR during the forecast period
Over the course of the forecast period, the diagnostic laboratories segment is expected to have the highest CAGR. Diagnostic laboratories offer a wide variety of tests for the diagnosis and monitoring of diseases, which makes them essential to the healthcare process. Additionally, the need for advanced testing services has increased due to the rising prevalence of chronic conditions and the development of diagnostic technologies. Due to their crucial role in precision and personalized medicine, as well as their partnerships with pharmaceutical companies and healthcare providers, diagnostic laboratories are well-positioned for continued growth in this market.
Region with largest share:
North America is expected to hold the largest share. Many factors contribute to this prominence, including substantial investments in research and development, a well-established network of diagnostic laboratories, a high prevalence of chronic diseases, and an advanced healthcare infrastructure. The United States, in particular, is a major factor driving market growth because of its strong healthcare system and ongoing advancements in diagnostic technology. Furthermore, North America continues to dominate the market for diagnostic laboratories, in part because of the region's emphasis on personalized healthcare and precision medicine.
Region with highest CAGR:
The diagnostic laboratories market is expected to grow at the highest CAGR in the Asia-Pacific (APAC) region, due to factors such as growing demand for advanced diagnostic services, rising healthcare awareness, and the prevalence of infectious and chronic diseases. Alongside significant advancements in diagnostic technologies, nations like China, India, and Japan are investing heavily in their healthcare infrastructure. Moreover, the region's strong growth in the diagnostic laboratory market is also attributed to the emphasis on preventive healthcare and the adoption of precision medicine practices in several APAC countries.
Key players in the market
Some of the key players in Toxicology Drug Screening market include Covance, Inc., Agilent Technologies Inc., Enzo Life Sciences Inc., Danaher, Alere, Inc., BioReliance, Inc., Eurofins Scientific, Bio-Rad Laboratories Inc., Promega Corporation, GE Healthcare, Thermo Fisher Scientific Inc and Charles River Laboratories International Inc.
Key Developments:
In November 2023, Danaher will acquire all of the outstanding shares of Abcam for $24 per share in cash, for a total enterprise value of approximately $5.7bn including assumed indebtedness and net of acquired cash.
In September 2023, Agilent Technologies Inc. (NYSE: A) recently signed a Research Collaboration Agreement (RCA) with the National Cancer Centre Singapore (NCCS) outlining their collaboration to accelerate translational cancer research on the genomic landscape of Asian-prevalent cancers over the next two years.
In July 2023, Bio-Rad Laboratories, Inc. and QIAGEN N.V., today announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court of Delaware pursuant to a global settlement and patent cross-licensing agreement relating to digital PCR technology.
Types Covered:
• Cardiovascular Disease Drug Screening
• Obesity Drug Screening
• Diabetes Drug Screening
• Other Types
Test Types Covered:
• Acute Systemic Toxicity
• Dermal Toxicity
• Carcinogenicity
• Ocular Toxicity
• Genotoxicity
• Neurotoxicity
• Organ-Specific Toxicity
• Other Test Types
Technologies Covered:
• High-Throughput Screening
• Genomics
• Transcriptomics
• Toxicogenomics
• Molecular Screening
• Other Technologies
End Users Covered:
• Hospitals and Trauma Centers
• Forensic Laboratories
• Diagnostic Laboratories
• Rehabilitation Centers
• Pharmaceutical & Biotechnology Companies
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Toxicology Drug Screening Market, By Type
5.1 Introduction
5.2 Cardiovascular Disease Drug Screening
5.3 Obesity Drug Screening
5.4 Diabetes Drug Screening
5.5 Other Types
6 Global Toxicology Drug Screening Market, By Test Type
6.1 Introduction
6.2 Acute Systemic Toxicity
6.3 Dermal Toxicity
6.4 Carcinogenicity
6.5 Ocular Toxicity
6.6 Genotoxicity
6.7 Neurotoxicity
6.8 Organ-Specific Toxicity
6.9 Other Test Types
7 Global Toxicology Drug Screening Market, By Technology
7.1 Introduction
7.2 High-Throughput Screening
7.3 Genomics
7.4 Transcriptomics
7.5 Toxicogenomics
7.6 Molecular Screening
7.7 Other Technologies
8 Global Toxicology Drug Screening Market, By End User
8.1 Introduction
8.2 Hospitals and Trauma Centers
8.3 Forensic Laboratories
8.4 Diagnostic Laboratories
8.5 Rehabilitation Centers
8.6 Pharmaceutical & Biotechnology Companies
8.7 Other End Users
9 Global Toxicology Drug Screening Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Covance, Inc.
11.2 Agilent Technologies Inc.
11.3 Enzo Life Sciences Inc.
11.4 Danaher
11.5 Alere, Inc.
11.6 BioReliance, Inc.
11.7 Eurofins Scientific
11.8 Bio-Rad Laboratories Inc.
11.9 Promega Corporation
11.10 GE Healthcare
11.11 Thermo Fisher Scientific Inc.
11.12 Charles River Laboratories International Inc.
List of Tables
1 Global Toxicology Drug Screening Market Outlook, By Region (2021-2030) ($MN)
2 Global Toxicology Drug Screening Market Outlook, By Type (2021-2030) ($MN)
3 Global Toxicology Drug Screening Market Outlook, By Cardiovascular Disease Drug Screening (2021-2030) ($MN)
4 Global Toxicology Drug Screening Market Outlook, By Obesity Drug Screening (2021-2030) ($MN)
5 Global Toxicology Drug Screening Market Outlook, By Diabetes Drug Screening (2021-2030) ($MN)
6 Global Toxicology Drug Screening Market Outlook, By Other Types (2021-2030) ($MN)
7 Global Toxicology Drug Screening Market Outlook, By Test Type (2021-2030) ($MN)
8 Global Toxicology Drug Screening Market Outlook, By Acute Systemic Toxicity (2021-2030) ($MN)
9 Global Toxicology Drug Screening Market Outlook, By Dermal Toxicity (2021-2030) ($MN)
10 Global Toxicology Drug Screening Market Outlook, By Carcinogenicity (2021-2030) ($MN)
11 Global Toxicology Drug Screening Market Outlook, By Ocular Toxicity (2021-2030) ($MN)
12 Global Toxicology Drug Screening Market Outlook, By Genotoxicity (2021-2030) ($MN)
13 Global Toxicology Drug Screening Market Outlook, By Neurotoxicity (2021-2030) ($MN)
14 Global Toxicology Drug Screening Market Outlook, By Organ-Specific Toxicity (2021-2030) ($MN)
15 Global Toxicology Drug Screening Market Outlook, By Other Test Types (2021-2030) ($MN)
16 Global Toxicology Drug Screening Market Outlook, By Technology (2021-2030) ($MN)
17 Global Toxicology Drug Screening Market Outlook, By High-Throughput Screening (2021-2030) ($MN)
18 Global Toxicology Drug Screening Market Outlook, By Genomics (2021-2030) ($MN)
19 Global Toxicology Drug Screening Market Outlook, By Transcriptomics (2021-2030) ($MN)
20 Global Toxicology Drug Screening Market Outlook, By Toxicogenomics (2021-2030) ($MN)
21 Global Toxicology Drug Screening Market Outlook, By Molecular Screening (2021-2030) ($MN)
22 Global Toxicology Drug Screening Market Outlook, By Other Technologies (2021-2030) ($MN)
23 Global Toxicology Drug Screening Market Outlook, By End User (2021-2030) ($MN)
24 Global Toxicology Drug Screening Market Outlook, By Hospitals and Trauma Centers (2021-2030) ($MN)
25 Global Toxicology Drug Screening Market Outlook, By Forensic Laboratories (2021-2030) ($MN)
26 Global Toxicology Drug Screening Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
27 Global Toxicology Drug Screening Market Outlook, By Rehabilitation Centers (2021-2030) ($MN)
28 Global Toxicology Drug Screening Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
29 Global Toxicology Drug Screening Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
